SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-16-085037
Filing Date
2016-02-29
Accepted
2016-02-29 17:08:07
Documents
99
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v429662_10k.htm 10-K 2090213
2 EXHIBIT 10.12 v429662_ex10-12.htm EX-10.12 461158
3 EXHIBIT 10.13 v429662_ex10-13.htm EX-10.13 78709
4 EXHIBIT 21.1 v429662_exh21x1.htm EX-21.1 2995
5 EXHIBIT 23.1 v429662_exh23x1.htm EX-23.1 4023
6 EXHIBIT 31.1 v429662_exh31x1.htm EX-31.1 14292
7 EXHIBIT 31.2 v429662_exh31x2.htm EX-31.2 14272
8 EXHIBIT 32 v429662_exh32.htm EX-32 5649
15 GRAPHIC tex10-12_logo.jpg GRAPHIC 9579
16 GRAPHIC line.gif GRAPHIC 43
17 GRAPHIC spacer.gif GRAPHIC 43
18 GRAPHIC v429662_chrt-pipeline.jpg GRAPHIC 118661
19 GRAPHIC v429662_chrt-bar1.jpg GRAPHIC 69769
20 GRAPHIC v429662_chrt-line1.jpg GRAPHIC 140967
21 GRAPHIC v429662_chrt-bar2.jpg GRAPHIC 135413
22 GRAPHIC v429662_chrt-bar3.jpg GRAPHIC 218348
23 GRAPHIC v429662_chrt-line2.jpg GRAPHIC 154413
  Complete submission text file 0001144204-16-085037.txt   12236916

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT icpt-20151231.xml EX-101.INS 3073945
10 XBRL TAXONOMY EXTENSION SCHEMA icpt-20151231.xsd EX-101.SCH 56619
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE icpt-20151231_cal.xml EX-101.CAL 60057
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE icpt-20151231_def.xml EX-101.DEF 163947
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE icpt-20151231_lab.xml EX-101.LAB 420100
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icpt-20151231_pre.xml EX-101.PRE 384372
Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35668 | Film No.: 161469322
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences